Monday, April 8, 10:18 AM
Strategic Diagnostics (SDIX +9.7%) sells the assets of its Life Science business to OriGene Technologies for $16M. The sale represents substantially all of the assets of SDIX and has agreed to offer employment to a substantial majority of SDIX's employees.
Comment![Healthcare, On the Move]